KCNA3 and COVID-19: Moreover, by demonstrating the differentially regulated pathways as a result of dexamethasone treatment in severe COVID-19 patients, we provide evidence that decreased expression of Kv1.3 channels in PBMCs mediates the immunosuppressive effect of dexamethasone.